Table E5.

Sensitivity analysis with entropy balancing

	Adjusted odds ratio or β-coefficient (95% CI)	P value
Mortality
Early-Staged	1.16 (0.20-6.77)	.87
Late-Staged	1.83 (0.60-5.63)	.29
Stroke
Early-Staged	1.67 (0.47-5.92)	.43
Late-Staged	2.22 (0.84-5.85)	.11
Post-procedural hemorrhage
Early-Staged	1.53 (0.20-11.8)	.69
Late-Staged	1.18 (0.30-4.72)	.81
Blood transfusion
Early-Staged	0.60 (0.27-1.32)	.21
Late-Staged	1.27 (0.80-2.02)	.31
Acute kidney injury
Early-Staged	3.56 (1.77-7.16)	<.001
Late-Staged	2.53 (1.52-4.20)	<.001
Infectious complication
Early-Staged	1.48 (0.71-3.07)	.30
Late-Staged	0.88 (0.52-1.49)	.64
Pacemaker implantation
Early-Staged	1.57 (0.89-2.78)	.12
Late-Staged	1.03 (0.68-1.55)	.90
Non-home discharge
Early-Staged	1.98 (1.28-3.06)	.002
Late-Staged	4.25 (3.20-5.65)	<.001
Post-TAVR length of stay, d
Early-Staged	0.8 (−0.1-1.6)	.07
Late-Staged	0.1 (−0.3-0.4)	.62
Total length of stay, d
Early-Staged	4.7 (3.5-5.8)	<.001
Late-Staged	4.0 (3.5-4.4)	<.001
Total hospitalization costs per $1000
Early-Staged	8.1 (2.6-13.7)	.004
Late-Staged	11.9 (8.9-14.9)	<.001
30-Day readmission
Early-Staged	1.21 (0.65-2.23)	.55
Late-Staged	1.30 (0.85-2.01)	.23

CI, Confidence interval; TAVR, transcatheter aortic valve replacement.